We must work to prevent and prepare for other pandemics while fighting against COVID-19

DUBAI, 1 February 2022 – Global experts have stressed the urgent need for the international community to collaborate in preparedness and prevention against new pandemics, particularly in regard to protecting vulnerable populations.

‘The Next Wave | Preventing and Preparing to Beat Future Pandemics’ event – held in association with the World Health Organization (WHO) and the Mohammed bin Rashid University of Medicine and Health Sciences

Speakers at the hybrid ‘The Next Wave | Preventing and Preparing to Beat Future Pandemics’ event – held in association with the World Health Organization (WHO) and the Mohammed bin Rashid University of Medicine and Health Sciences as part of Expo 2020 Dubai’s Health and Wellness Week – underscored that the fight against COVID-19 must continue as long as people remain without access to vaccinations – a figure that currently amounts to roughly three billion people, mostly in low-income countries.

Dr Seth Berkley, CEO at Gavi, the Vaccine Alliance, which is a co-lead on COVAX, a global initiative aimed at equitable access to COVID-19 vaccines, delivering more than 1 billion doses in less than a year, said: “COVAX has proven that it can deliver, but we faced obstacles including a lack of early at-risk funding, vaccine awarding, export restrictions and scaling up of manufacturing, which led to delays in equitable access that we cannot afford.”

Dr Berkley urged leaders from public and private sectors to renew their support and help raise the minimum needed USD 5.2 billion in additional funds over the next three months as part of an initiative titled the Gavi COVAX AMC 2022 Investment Opportunity. “This [investment] will help COVAX create a pandemic vaccine pool, a buffer to protect its supply in case of future bottlenecks, and meet the emerging needs of countries, which is ultimately what it will take to stifle this virus,” he said.

Dr Seth Berkley, CEO at Gavi, the Vaccine Alliance, which is a co-lead on COVAX, a global initiative aimed at equitable access to COVID-19 vaccines

Dr Rhoda Wanyenze, Professor and Dean, School of Public Health, Makerere University, spoke about the effects of measures to limit the spread of COVID-19 in Africa, and specifically Uganda, the Democratic Republic of Congo, Nigeria and Senegal. Such measures often restricted access to food, water and education in vulnerable communities, and hampered access to healthcare services for other diseases, which led to Ebola and polio outbreaks.

Dr Donald Kaberuka, Chair, The Global Fund Board, said: “We cannot separate old and new pandemics, but instead need a package that handles all of them together… We have to invest in dealing with COVID because it is a danger to [progress on] other pandemics, which have been killing many more people than COVID itself, like AIDS and malaria. These are largely a problem in the Global South rather than wealthy countries, and therefore the attention and bandwidth is narrower – and this is a huge risk for the achievements of the last 25 years.”

Discussing zoonotic diseases that are at the root of many pandemics, Dr Neil Vora, pandemic prevention fellow, Conservation International, argued that pandemic prevention – such as combatting deforestation to reduce human wildlife interaction and regulating wildlife trade and markets – is far more economical and effective. “If implemented properly, pandemic prevention activities would cost USD 10-20 billion annually, compared to the millions of lives and trillions of dollars lost from a pandemic such as COVID,” said Dr Vora.

Moreover, Professor Andrew Cunningham, Deputy Director of Science, Institute of Zoology, Zoological Society of London, highlighted that the drivers of zoonotic disease emergence are also the force behind biodiversity loss and climate change, meaning that investing in pandemic prevention could address several global challenges at once.

The drivers of zoonotic disease emergence are also the force behind biodiversity loss and climate change, meaning that investing in pandemic prevention could address several global challenges at once.

Health and Wellness Week is one of 10 Theme Weeks held under Expo 2020’s Programme for People and Planet, offering an exchange of inspiring new perspectives to address the greatest challenges and opportunities of our time.

ameerul.hasan@thechangemakers.news

Innovation and technology took centre stage at the Inaugural Future Health Summit

Dubai, United Arab Emirates, 26 January 2022: Senior government healthcare officials, CEOs and visionaries from around the world, attended the inaugural Future Health Summit last night, Tuesday 25 January, to hear from a range of experts on the future of the healthcare and laboratory industries.

Healthcare industry experts last night underscored the need for healthcare reform, efficiencies in healthcare spending, and utilising the transformative power of the digital era

The invitation-only, in-person summit, organised by the MENA region’s leading exhibitions for the healthcare industry, Arab Health and Medlab Middle East, addressed some of the most critical issues impacting the global healthcare industry and the barriers and opportunities for securing sustainable healthcare for all.

Open remarks were made by H.E Dr Amin Hussain Al Ameeri, Asst. Undersecretary of Health Regulation Sector, UAE Ministry of Health and Prevention. Lord Stephen Carter, Baron Carter of Barnes, CEO Informa, welcomed guests and underscored the importance of the healthcare industry coming together to discuss and debate the way forward. He said:

“First and foremost, it is a testament to the discipline, the professionalism, and the dedication of the authorities in the UAE to make this a safe place for people to meet, to trade, to learn, and to transact. What we are seeing at Arab Health and Medlab Middle East is a showcase at the beginning of the year for the rest of the world as we begin to see ourselves move on from the pandemic.

Arab Health and Medlab Middle East, addressed some of the most critical issues impacting the global healthcare industry and the barriers and opportunities for securing sustainable healthcare for all.

“We hope that as we move from pandemic to endemic, as we learn to live alongside a change in circumstance and everything that goes with it, we can share those learnings.

“If we’ve learned nothing over the last two years, we’ve learned that sustainability and innovations are now centre stage for countries, for companies and industrial sectors. And I know of no topics that are more important for the markets we serve.”

One of the highlights of the evening was a panel discussion focused on sustainability, innovation, and the future of healthcare.

Moderated by Marwan Abdulaziz Janahi, Managing Director, Dubai Science Park with panellists included; Dr Alaa Murabit, Medical Doctor, Global Security Strategist, Women’s Rights Advocate and United Nations High-Level Commissioner on Health, Employment & Economic Growth; Dr Sameh El-Saharty, Program Leader for Human Development, GCC Country Department, The World Bank; and Veronica Beneitez Piñero, Deputy Head of Unit, Transition and Business, European Commission.

It has been an advocacy of the healthcare community to urge and usher in universal healthcare as a shared understanding that health care is a fundamental human right.

The group explored the innovative concepts in securing sustainable healthcare, addressing healthcare reform, gaining efficiencies in healthcare spending, and capitalising on the transformative power of the digital era.

Discussing the actions required to strengthen health financing systems, especially for lower-income countries, Dr Alaa said: “It has been an advocacy of the healthcare community to urge and usher in universal healthcare as a shared understanding that health care is a fundamental human right. What we have seen the most clearly in countries that are accountable for the percentage of financing that they put into health care and hold themselves accountable to that number have done best. Nigeria is a good example of this.”

One of the key learning from the panel discussion was the importance of recognising health system should not be looked upon in silo, as every government department has a role to play.

According to Dr Saameh, only 20% of healthcare outcomes result from healthcare delivery systems. He said: “Clinics and hospitals contribute only 20% of health outcomes surprisingly 80% are due to socio-economic, behavioural, and environmental factors.

“I think there is a role for different sectors to play in terms of improving health outcomes. Road safety, banning smoking and adding taxes to tobacco products, healthy eating in schools for children, these are the roles of many different government departments, but they need to come together for the benefit of the healthcare sector.”

As part of the evening, a range of cutting-edge technologies was showcased by leading innovators within the healthcare and laboratory sector. They included insights from Ionut Taranu, Head of Marketing and Healthcare Consulting, Roche Middle East, who underscored the importance of developing strong partnerships. He was joined by Dr Bernd Onesorge, President EMEA, Siemens Healthcare, who outlined the latest innovations in healthcare, while Damian Halloran, VP Infectious Disease, Emerging Markets, Rapid Diagnostics, Abbot Laboratories, outlined the future of rapid diagnostics.

Arab Health and Medlab Middle East continue until tomorrow, 27 January, at the Dubai World Trade Centre.

Medlab Middle East delves into the global preparedness of the next pandemic

Dubai, United Arab Emirates, 26 January 2022: Entering the third year of the COVID-19 pandemic, and with more than 355 million confirmed cases, this year, Medlab Middle East Congress hosted a special track entitled COVID-19 updates, which opened under the theme ‘Are we prepared for the next pandemic?’.

Medlab Middle East hosts a special track to determine the global preparedness of the next pandemic

The track brought together global experts and leading voices in SARS-CoV-2 virology, immunology, vaccines, clinical care, therapeutic guidelines, and trials.

The speakers included Dr Mohammed Yousef Karim, Division Chief of Hematopathology, Sidra Medicine; Dr Gehad Eltayeb ElGhazali, Consultant Physician and Service Lead Immunologist, Sheikh Khalifa Medical City; Dr Jehad Saleh Abdalla, Consultant Infectious Diseases, Rahba Hospital; and her H.E Dr Farida Al Hosani, official spokesperson UAE Health sector, and Executive Director, ADPHC.

Key topics included the immunology of COVID-19 – the mechanisms, clinical outcomes, diagnostics, and other perspectives, as well as further developments and research on COVID 19 vaccines, new variants and the skills, tools and technologies required to combat future outbreaks.

The track also included the latest science on COVID-19, reviewing different types of tests, vaccines, ongoing research – in addition to deliberations on how lab professionals continue to provide lab services and support.

To date, there have been more than 355 million confirmed cases of COVID-19

Rejoy Penacerrada, Conference Director for Informa Markets, said: “Medlab Middle East developed this dedicated track specifically to enable laboratory professionals to evaluate COVID-19 management strategies in the lab by identifying the latest updates in diagnostic testings, discussing post-COVID-19 preventive measures and appraising research and development on vaccines, all vital components in the fight against the spread of COVID-19.”

According to the Centre for Diseases Control and Prevention (CDC), COVID-19 tests can detect either SARS-CoV-2, the virus that causes COVID-19, or antibodies that your body makes after getting COVID-19 or after getting vaccinated. A viral test, including rapid tests and laboratory tests, tells you if you are infected with SARS-CoV-2, use samples from the nose or mouth. In contrast, “antibody” or “serology” tests may tell you if you have had a past infection with the virus that causes COVID-19.

This year, the Medlab Middle East Exhibition showcases affordable and high-performance COVID-19 testing solutions from across the globe, with more than 400 exhibitors and 38 exhibiting countries, including ten country pavilions giving a truly international representation of COVID-19 management solutions from across the world.

For example, UAE-based Gulf Med FZCO is at Medlab Middle East to highlight the BioGX pixel 16 real-time PCR testing platform, which can run 16 individual patient samples in approximately 45 minutes. Similarly, ThermoFisher Scientific are at Medlab Middle East to promote the QuantStudio Absolute Q Digital PCR System, which enables all the necessary steps for digital PCR – compartmentalising, thermal cycling, and data acquisition – to be conducted on a single instrument. It also allows for 95% of the sample to be analysed, delivering more accurate data to help researchers find the information they are seeking.

Medlab Middle East continues until 27 January 2022

Meanwhile, Chinese-based Wondfo is highlighting a clinical management solution for COVID-19 patients, looking at the inflammatory response, bacterial co-infections, cardiac damage and coagulopathy, helping healthcare professionals make clinical decisions and evaluate after treatment.

Seegene Inc, the Korean manufacturer of in vitro diagnostic products, showcased their latest all-in-one solution for molecular testing. The fully automated system on the show, the STARlet-AIOS, can determine the exact cause of various ailments, from a dry cough and fever to headaches and pneumonia.

According to Bassam Bibi, Divisional Vice President, Abbott Rapid Diagnostics, a highlight for him this year at Medlab Middle East is self-test rapid diagnostic antigen, he said: “We have created a vending machine, which is being shown for the first time here at Medlab that provides rapid self-tests. The role of rapid diagnostics is becoming more and more important, which is something we have recognised, and are showcasing this year.”

Medlab Middle East continues today, focusing on Clinical Microbiology and Clinical Chemistry as they return to the conference schedule. Keys sessions include Protein Markers & Proteomics, and Point of Care Testing & Hot Topics in Clinical Chemistry.

As part of Informa’s commitment to providing the highest hygiene and safety levels, the 2022 edition of Medlab Middle East will again take place under the protocols introduced via the company’s Informa AllSecure health and safety mandate. The enhanced measures include 35 guidelines covering all aspects of cleaning and hygiene, social distancing measures, and the use of PPE, screening, and a track and trace in conjunction with local authorities.

A virtual showcase of Medlab Middle East will continue until 28 February.

For more information, please visit http://www.medlabme.com.

ameerul.hasan@thechangemakers.news